Highlights Cognetivity Neurosciences Ltd.

Equities

CGN

CA19243C1005

Market Closed - Canadian Securities Exchange Other stock markets 11:17:34 08/05/2024 pm IST			5-day change	1st Jan Change
0.015 ^CAD	0.00%		0.00%	0.00%

2023	Cognetivity Neurosciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	CI
2023	Cognetivity Neurosciences Ltd. announced that it has received CAD 0.01 million in funding	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cognetivity Neurosciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	29/12	CI
Cognetivity Neurosciences Ltd. and Uc Health Partner to Improve Early Detection of Cognitive Impairment in Usa	11/23/11	CI
Cognetivity Neurosciences Ltd. Announces Collaboration with the Mediclinic Group	03/23/03	CI
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	30/23/30	CI
Cognetivity Neurosciences Ltd. Announces Eisai's Leqembi Approval for the Treatment of Alzheimer's Disease	07/23/07	CI
Cognetivity Neurosciences Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2023	30/23/30	CI
Clairvo Technologies, Inc. Announces Strategic Partnership with Cognetivity Neurosciences, Inc	13/23/13	CI
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Full Year Ended January 31, 2023	10/23/10	CI
Cognetivity Neurosciences Ltd. Announces Collaboration with the Alzheimer's Society to Further Expand Its AI Algorithms	31/23/31	CI
Cognetivity Neurosciences Ltd. Announces Agreement with Mitsui Sumitomo Aioi Life Insurance of Japan to Provide CognICA Technology to Customers	25/23/25	CI
Cognetivity Neurosciences Enters Commercial Agreement with Conka	15/23/15	CI
Cognetivity Neurosciences Announces Commercial Deployment at Leading Psychiatry and Neurology Centre in UAE	23/23/23	CI
Cognetivity Announces Further Scientific Evidence of its AI-Powered CognICA(TM) Platform's Ability to Detect and Monitor Cognitive Impairment in Patients With Multiple Sclerosis	22/23/22	CI
Cognetivity Neurosciences Ltd. Announces Release an Update Version of Its Tool, CognICATM	14/23/14	CI
Cognetivity Neurosciences Ltd.'s CognICA Platform Successfully Monitors Cognitive Performance in Alzheimer's Patients Receiving Disease- Modifying Therapy	24/23/24	CI
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	17/22/17	CI
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	30/22/30	CI
Cognetivity Neurosciences Ltd. Announces Commercial Pilot with Large US Healthcare Provider	20/22/20	CI
Cognetivity Neurosciences Ltd. Collaborating with Baylor College of Medicine in Ground-Breaking Study on OCD	13/22/13	CI
Cognetivity Neurosciences Ltd. Launches Paid Pilot Project with MS&AD Group Companies	21/22/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cognetivity Neurosciences Ltd.

Equities

CGN

CA19243C1005

Highlights

Filters